Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released Aug 3, 2018, after the close
10-Q filed Aug 3, 2018, 34 days after period end · 0001299130-18-000057
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Revenue | $21.58M | $20.07M | $20.75M | $24.94M |
| Net Income | -$22.54M | -$25.54M | -$18.50M | -$11.94M |
| EPS Diluted | -$0.17 |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| -$0.26 |
| -$0.21 |
| -$0.16 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
